don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"The Uromigos","authorlink":""},"src":"https:\/\/anchor.fm\/s\/13347ea8\/podcast\/play\/47872327\/https:\/\/d3ctxlq1ktw2nl.cloudfront.net\/staging\/2022-1-18\/9edc7b6e-99c1-6ed9-d32c-1faddb4155e3.mp3","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202206\/9aed5f-417e-e2ab-039fa5_800.jpg"},"title":"Episode 156: ASCO GU 2022 1st line olaparib and durvalumab in bladder cancer","link":"javascript:;","id":"item-10064141"}]
